It was reported that on (b)(6) 2018, a 25 mm amplatzer pfo occluder was successfully implanted.On (b)(6) 2022, the patient was admitted with a fever of unknown origin.Blood cultures were performed and came back (b)(6) for (b)(6).Tee was also performed and revealed left sided endocarditis and large vegetation adhering to the patient's implanted pfo occluder.The patient also was found to have right-sided weakness on (b)(6) 2022 and found to have a left middle cerebral artery (mca) infraction with right subarachnoid hemorrhage (sah).Medication was administered to treat the patient.On (b)(6) 2022, the patient passed away due to septic shock.The patient had not had a history of endocarditis.The physician doesn't allege a malfunction on the abbott device, but that the endocarditis was due to the vegetation on the device.
|
An event of fever, endocarditis and death due to stroke were reported.A returned device assessment could not be performed as the device remained implanted and was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|